局部区域晚期鼻咽癌同期放化疗联合辅助化疗不良反应的临床分析(3)
 |
| 第1页 |
参见附件(2449KB，3页)。
参 考 文 献
[1] Chua DT, Sham JS, Kwong DL, et al. Treatment outcome after radiotherapy alone for patients with Stage Ⅰ-Ⅱ nasopharyngeal cacinoma. Cancer,2003, 98(1):74-78.
[2] 华贻军,洪明晃,罗东华,等.406例鼻咽癌患者预后多因素分析.中国肿瘤临床,2005,32(8):435-438.
[3] Al-sarraf M, LeBlanc M, Giri PGS, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase Ⅲ randomized Intergroup Study 0099.Clin Oncol,1998,16:1310-1317.
[4] 陈勇,梁少波,毛燕萍,等.局部区域晚期鼻咽癌同期放化疗联合辅助化疗的前瞻性Ⅲ期临床研究.中国肿瘤临床,2008,35(14):785-789.
[5] 赵充,管讯行.鼻咽癌放化疗综合治疗临床研究现状.中华肿瘤防治杂志,2006,13(6):61-64.
[6] Wee J.Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage Ⅲ and IV nasopharyngeal cancer of the endemic variety.Clin Oncol,2005,23(27):6730-6738.
[7] Chua DT, Sham JS, Au GK, et al.Conocomitant chemoirradiation for stage Ⅲ-IV nasopharyngeal carcinoma in Chinese patients; results of a matched cohort analysis. Int J Radiat Oncol Biol Phys, 2002,53(2):334-343.
[8] Jens Overgaard.Chemoradiotherapy of head and neck cancer - Can the bumble bee fly? .Radiotherapy and Oncology,2009,92:1-3.
[9] 洪明晃,麦海强,罗东华.N2-3鼻咽癌患者辅助化疗的成本效果分析.中国肿瘤,2000,9(12):548-549.
[10] 刘丽琴,张西志.辅助化疗对高危远处转移鼻咽癌患者生存率的影响. 实用癌症杂志,2003,18(4):394-396.
[11] Kwong DL, Sham JS, Au GK,Chua DT.Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.Clin Oncol, 2004, V22N13:2643-2653.
您现在查看是摘要介绍页，详见PDF附件(2449KB，3页)。